4/4
02:00 pm
trda
The United Mitochondrial Disease Foundation Announces Inaugural Venture Philanthropy Investment; The Mito Fund Invests $500k in Pierrepont Therapeutics, Inc.
Low
Report
The United Mitochondrial Disease Foundation Announces Inaugural Venture Philanthropy Investment; The Mito Fund Invests $500k in Pierrepont Therapeutics, Inc.
3/19
06:43 am
trda
Entrada Therapeutics, Inc. (NASDAQ:TRDA) Analysts Just Slashed This Year's Estimates [Yahoo! Finance]
Low
Report
Entrada Therapeutics, Inc. (NASDAQ:TRDA) Analysts Just Slashed This Year's Estimates [Yahoo! Finance]
3/18
02:53 pm
trda
Entrada Therapeutics, Inc. (NASDAQ: TRDA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Low
Report
Entrada Therapeutics, Inc. (NASDAQ: TRDA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
3/13
07:00 am
trda
Entrada Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
High
Report
Entrada Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
2/7
07:18 am
trda
Entrada Therapeutics to Present at Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Entrada Therapeutics to Present at Upcoming Investor Conferences [Yahoo! Finance]
2/7
07:00 am
trda
Entrada Therapeutics to Present at Upcoming Investor Conferences
Low
Report
Entrada Therapeutics to Present at Upcoming Investor Conferences